“…The remaining 25 studies included in this review investigated the development of new drug targets and therapies or focused on direct LG regeneration using SCs from various sources (Table 1). Studies were published between June 2008 (Zoukhri et al, 2008) and September 2020 (Yu et al, 2020) in the United States (Ali et al, 2017; Aluri et al, 2017; Basova et al, 2017; Gromova et al, 2017; Lu et al, 2017; You et al, 2012; Zoukhri et al, 2008), China (Liu, 2017; Xiao & Zhang, 2020; Xie et al, 2015; Yu et al, 2020; Zhang et al, 2014), Germany (Dietrich, Ott, et al, 2019; Dietrich, Roth, et al, 2019; Roth et al, 2015), Canada (Abughanam et al, 2019; Yao et al, 2019), Japan (Hirayama et al, 2013; Mishima et al, 2012), Denmark (Moller‐Hansen et al, 2020), Korea (Jeong et al, 2021; Lee et al, 2015), Brazil (Bittencourt et al, 2016), Spain (Villatoro et al, 2015) and Turkey (Beyazyildiz et al, 2014) (Figure 4).…”